ALLMedicine™ Choroidal Melanoma Center

May 3rd, 2022 - Up to approximately 45 patients who are planned to receive plaque radiotherapy for the treatment of IL/CM based on the expert judgment of the Investigator are planned to be enrolled.

Apr 30th, 2022 - To investigate the potential clinical benefit of a two-beam arrangement technique using three-dimensional (3D) imaging of uveal melanoma (UM) patients treated with proton therapy and a dedicated eyeline. Retrospective CT-based treatment plans of 3...

Apr 12th, 2022 - Plaque brachytherapy is the most common procedure for the treatment of small choroidal melanoma, especially in posteriorly located tumors. However, there is only little information on outcome after treatment with stereotactic radiosurgery, for exa...

Apr 1st, 2022 - To quantify potential loss (loss of vision) and gain (freedom from metastasis) in patients with small choroidal melanoma treated after period of surveillance to document growth. A total of 167 patients with small choroidal melanoma (size 5.0-16.0 ...

Mar 23rd, 2022 - Extrascleral Extension from Choroidal Melanoma Diagnosed on Doppler Ultrasound.|2022|Lemaître S,Thaung C,Damato B,|diagnostic imaging,diagnostic imaging,

Nov 15th, 2021 - NEW ORLEANS, La. – Choroidal melanoma is a rare cancer that affects the back of the eye. If the tumor grows, it can cause the retina to detach, leading to vison loss. And if it spreads to other parts of the body, it can be fatal. There are no appr...

May 3rd, 2022 - Up to approximately 45 patients who are planned to receive plaque radiotherapy for the treatment of IL/CM based on the expert judgment of the Investigator are planned to be enrolled.

Mar 7th, 2022 - Melanoma arising from the choroid and ciliary body is the most common primary intraocular cancer. The Collaborative Ocular Melanoma Study (COMS) randomized clinical trial of I-125 brachytherapy versus enucleation for medium-sized choroidal melanom...

Nov 15th, 2021 - NEW ORLEANS, La. – Choroidal melanoma is a rare cancer that affects the back of the eye. If the tumor grows, it can cause the retina to detach, leading to vison loss. And if it spreads to other parts of the body, it can be fatal. There are no appr...

Aug 7th, 2020 - This study is a prospective, open-labelled, monocentric trial. The aim is to observe, in patient with choroidal melanoma (any stage of the disease), the prevalence of the circulating tumor DNA at the diagnostic and its evolution during 3 years. Th...

May 6th, 2020 - The radiation maculopathy is a consequence of radiotherapy for treatment of choroidal melanoma. The radiation maculopathy is characterized by the compromission of the macular microvasculature that can lead to the leakage, lipid exudates, hemorrhag...

Nov 15th, 2021 - NEW ORLEANS, La. – Choroidal melanoma is a rare cancer that affects the back of the eye. If the tumor grows, it can cause the retina to detach, leading to vison loss. And if it spreads to other parts of the body, it can be fatal. There are no appr...

Dec 5th, 2020 - Chris Barker, MD, PhD The unique biological characteristics of uveal melanoma have prompted the National Comprehensive Cancer Network (NCCN) to develop the first set of guidelines for the diagnosis and management of the rare but deadly cancer, ac...

May 13th, 2018 - Chris Barker, MD, PhD The unique biological characteristics of uveal melanoma have prompted the National Comprehensive Cancer Network (NCCN) to develop the first set of guidelines for the diagnosis and management of the rare but deadly cancer, acc...

Sep 25th, 2015 - Case Diagnosis Congenital hypertrophy of the retinal pigment epithelium (CHRPE) is often discovered as part of a workup to rule out malignant choroidal melanoma. The lesions of malignant melanoma would be elevated with deviated retinal vessels and...

Sep 25th, 2015 - Discussion CHRPE is a benign pigmented lesion that often raises suspicion for malignant choroidal melanoma. First described by Buettner in 1974, CHRPE appears as a flat, pigmented, well-demarcated lesion located at level of the RPE.[1,2,3,4] The l...